Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 113(36): E5308-17, 2016 09 06.
Artículo en Inglés | MEDLINE | ID: mdl-27540115

RESUMEN

Despite numerous reports implicating NADPH oxidases (Nox) in the pathogenesis of many diseases, precise regulation of this family of professional reactive oxygen species (ROS) producers remains unclear. A unique member of this family, Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox), respectively, the latter of which is functional in vascular smooth muscle cells (VSMC). In this manuscript, we identify critical requirement of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50; aka NHERF1) for Nox1 activation and downstream responses. Superoxide (O2 (•-)) production induced by angiotensin II (AngII) was absent in mouse EBP50 KO VSMC vs. WT. Moreover, ex vivo incubation of aortas with AngII showed a significant increase in O2 (•-) in WT but not EBP50 or Nox1 nulls. Similarly, lipopolysaccharide (LPS)-induced oxidative stress was attenuated in femoral arteries from EBP50 KO vs. WT. In silico analyses confirmed by confocal microscopy, immunoprecipitation, proximity ligation assay, FRET, and gain-/loss-of-function mutagenesis revealed binding of EBP50, via its PDZ domains, to a specific motif in p47(phox) Functional studies revealed AngII-induced hypertrophy was absent in EBP50 KOs, and in VSMC overexpressing EBP50, Nox1 gene silencing abolished VSMC hypertrophy. Finally, ex vivo measurement of lumen diameter in mouse resistance arteries exhibited attenuated AngII-induced vasoconstriction in EBP50 KO vs. WT. Taken together, our data identify EBP50 as a previously unidentified regulator of Nox1 and support that it promotes Nox1 activity by binding p47(phox) This interaction is pivotal for agonist-induced smooth muscle ROS, hypertrophy, and vasoconstriction and has implications for ROS-mediated physiological and pathophysiological processes.


Asunto(s)
ATPasas Asociadas con Actividades Celulares Diversas/metabolismo , ADN Helicasas/metabolismo , Hipertrofia/metabolismo , NADPH Oxidasa 1/genética , Fosfoproteínas/metabolismo , Proteínas/metabolismo , Intercambiadores de Sodio-Hidrógeno/metabolismo , ATPasas Asociadas con Actividades Celulares Diversas/genética , Proteínas Adaptadoras Transductoras de Señales , Angiotensina II/administración & dosificación , Angiotensina II/efectos adversos , Animales , ADN Helicasas/genética , Arteria Femoral/efectos de los fármacos , Arteria Femoral/metabolismo , Arteria Femoral/patología , Humanos , Hipertrofia/inducido químicamente , Hipertrofia/patología , Lipopolisacáridos/toxicidad , Ratones , Ratones Noqueados , Músculo Liso Vascular/metabolismo , Músculo Liso Vascular/patología , NADPH Oxidasa 1/metabolismo , Estrés Oxidativo/efectos de los fármacos , Fosfoproteínas/genética , Proteínas/genética , Especies Reactivas de Oxígeno/metabolismo , Intercambiadores de Sodio-Hidrógeno/genética , Superóxidos/metabolismo , Vasoconstricción/efectos de los fármacos , Vasoconstricción/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA